CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenues	$ 0	$ 0	$ 0	$ 0
Costs and Expenses
Operating expenses	493,000	431,000	1,626,000	1,387,000
Research and development expenses	82,000	50,000	665,000	145,000
Loss before other expense	(575,000)	(481,000)	(2,291,000)	(1,532,000)
Other expense
Interest and financing expense	(413,000)	(200,000)	(2,437,000)	(607,000)
Net loss	$ (988,000)	$ (681,000)	$ (4,728,000)	$ (2,139,000)
Net loss per common share, basic and diluted	$ (0.00)	$ (0.00)	$ (0.02)	$ (0.01)
Weighted average common shares outstanding, basic and diluted	298,834,404	251,732,417	286,120,559	243,167,707